Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.67 |
| ▸ | CCR1 | P32246 | 4/20 | 0.67 |
| ▸ | CCR5 | P51681 | 4/20 | 0.67 |
| ▸ | CCR8 | P51685 | 4/20 | 0.67 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | TP53 | P04637 | 3/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | HTT | P42858 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | ALPL | P05186 | 1/20 | 0.67 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.67 |
| ▸ | ALPI | P09923 | 1/20 | 0.67 |
| ▸ | ALPG | P10696 | 1/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | METAP1 | P53582 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Terpyridine SCHEMBL5047400 | 0.98 | KDM4E (0.64) | KDM4ECCR1CCR5CCR8LMNA | |
| SCHEMBL17132034 | 0.93 | CCR1 (0.63) | KDM4ECCR1CCR5CCR8LMNA | |
| SCHEMBL563123 | 0.92 | CCR1 (0.74) | KDM4ECCR1CCR5CCR8LMNA | |
| Dipyridyl SCHEMBL28342586 | 0.92 | CCR1 (0.74) | KDM4ECCR1CCR5CCR8LMNA | |
| Iodide SCHEMBL28395658 | 0.90 | CCR1 (0.71) | KDM4ECCR1CCR5CCR8LMNA | |
| Dipyridyl SCHEMBL4890661 | 0.90 | CCR1 (0.71) | KDM4ECCR1CCR5CCR8LMNA | |
| SCHEMBL23632748 | 0.85 | CCR1 (0.63) | KDM4ECCR1CCR5CCR8LMNA | |
| SCHEMBL1104803 | 0.84 | CCR1 (0.64) | KDM4ECCR1CCR5CCR8LMNA | |
| Dipyridyl SCHEMBL6495938 | 0.84 | CCR1 (0.61) | KDM4ECCR1CCR5CCR8LMNA | |
| SCHEMBL8009665 | 0.83 | CCR1 (0.65) | KDM4ECCR1CCR5CCR8LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530477-B2 | Cycloheptatriene molybdenum (0) precursors for deposition of molybdenum films | APPLIED MATERIALS, INC. (US) | 2022-12-20 | — | — | US | disclosed |
| US-20220220607-A1 | CYCLOHEPTATRIENE MOLYBDENUM (0) PRECURSORS FOR DEPOSITION OF MOLYBDENUM FILMS | APPLIED MATERIALS, INC. (US) | 2022-07-14 | — | — | US | disclosed |
| US-8507679-B2 | Heteroleptic, dual tridentate Ru(II) complexes as sensitizers for dye-sensitized solar cells | NATIONAL TSING HUA UNIVERSITY (TW) | 2013-08-13 | — | — | US | disclosed |
| US-20120073660-A1 | HETEROLEPTIC, DUAL TRIDENTATE RU(II) COMPLEXES AS SENSITIZERS FOR DYE-SENSITIZED SOLAR CELLS | NATIONAL TSING HUA UNIVERSITY (TW) | 2012-03-29 | — | — | US | disclosed |
| US-7420058-B2 | Compound for molecular electronic device having thiol anchoring group, method of synthesizing the compound, and molecular electronic device having molecular active layer obtained from the compound | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) | 2008-09-02 | — | — | US | disclosed |
| US-20070120121-A1 | Compound for molecular electronic device having thiol anchoring group, method of synthesizing the compound, and molecular electronic device having molecular active layer obtained from the compound | ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE | 2007-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530477-B2 | Cycloheptatriene molybdenum (0) precursors for deposition of molybdenum films | CISD2, SPR, CPNE4 | KDM4E 934/4885CCR1 352/4885CCR5 142/4885 |
| US-20120073660-A1 | HETEROLEPTIC, DUAL TRIDENTATE RU(II) COMPLEXES AS SENSITIZERS FOR DYE-SENSITIZED SOLAR CELLS | RUVBL2, RUVBL1, CCNL2 | KDM4E 3201/4885CCR1 1938/4885CCR5 3302/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.